CCCC
C4 Therapeutics Inc
Price:  
4.71 
USD
Volume:  
1,672,997.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CCCC WACC - Weighted Average Cost of Capital

The WACC of C4 Therapeutics Inc (CCCC) is 8.2%.

The Cost of Equity of C4 Therapeutics Inc (CCCC) is 11.40%.
The Cost of Debt of C4 Therapeutics Inc (CCCC) is 5.00%.

Range Selected
Cost of equity 8.20% - 14.60% 11.40%
Tax rate 0.60% - 1.00% 0.80%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 9.8% 8.2%
WACC

CCCC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.95 1.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 14.60%
Tax rate 0.60% 1.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 9.8%
Selected WACC 8.2%